All News

NACDS is launching a nationwide awareness campaign on the importance of getting the flu vaccine this fall.

AstraZeneca’s investigational coronavirus disease 2019 (COVID-19) vaccine candidate, AZD1222, has expanded into a phase 3 clinical trial.

The affordability of insulin is a constant topic of discussion for diabetics and their care providers. While the cost of medication was already an issue for many diabetic patients, it has been further compounded by the ongoing pandemic.

Here's the coronavirus-related news from this week that you should know.

In the letter, NCPA stated that investigations should probe problems associated with mail order prescription plans.

Abbott’s BinaxNOW COVID-19 Ag Card rapid test produces results in 15 minutes.

NACDS is urging states to provide clarity on pharmacist-provided childhood vaccinations, and enhance overall patient access to vaccines.

Bayshore Pharmaceuticals issued a voluntary recall of 2 lots of its extended-release metformin products due to high levels of NDMA.

Mylan has launched the first FDA-approved generic version of Biogen’s dimethyl fumarate (Tecfidera) for relapsing forms of multiple sclerosis.

NACDS is urging the Centers for Medicare & Medicaid Services (CMS) to change how pharmacy reimbursement rates are calculated for drug discount cards.

MJH Life Sciences™ today announced it will host “Debating the Road Back to School,” a free, live, one-hour webinar on Thursday, Aug. 20, at 6 p.m. EDT.

The National Community Pharmacists Association (NCPA) announced today its 2020 NCPA Annual Convention will be held virtually, October 18-19, 2020.

In a collaborative effort, the American Pharmacists Association and Walmart are offering free online training on opioid stewardship to all pharmacists and pharmacy technicians.

The US government and Moderna are collaborating to produce 100 million doses of investigational COVID-19 vaccine candidate mRNA-1273.

The opioid’s indication was based on several randomized controlled trials, where patients reported decreased pain.

Here's this week's coronavirus-related news you should know.

In an open letter, several health organizations urged the Trump Administration and Congress to recognize pharmacists as medical providers.

The grants are part of the administration’s continuing focus on rural health initiatives.

Esketamine (Spravato; Janssen) CIII nasal spray is the first FDA-approved antidepressant medication that improves depressive symptoms with the first dose in adults with major depressive disorder.

Asking for better pay, hours, or work benefits can be intimidating for pharmacists, but these strategies can help you get the rewards you deserve.

The FDA approved a cannabidiol oral solution treatment (Epidiolex, Greenwich Biosciences) for seizures associated with tuberous sclerosis complex.

The American Society of Health-System Pharmacists (ASHP) announced plans to hold the 2020 Midyear Clinical Meeting in December as an all-virtual experience.

NACDS, APhA, NCPA, and others warn that overlooking DIR fee reform will be detrimental to pharmacy viability.

In an open letter, the American Pharmacist Association’s (APhA) Board of Trustees called for Americans to continue following public health guidelines.

Responding to growing interest by industry stakeholders, the agency has offered draft guidance outlining quality considerations and other practical recommendations for cannabis and cannabis-derived compounds.

The American Pharmacists Association (APhA) urged Congress to take immediate action to expand coronavirus disease 2019 (COVID-19) testing services by granting pharmacists temporary provider status.

A global pharmacy organization is aiming to help pharmacists expand their role in immunization via a new resource.

SingleCare’s second annual Pharmacy Awards honors pharmacists and pharmacy technicians, the COVID-19 pandemic’s unsung health care heroes.